We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
RANDOMIZED CONTROLLED TRIAL
The effectiveness of extracorporeal shock wave therapy vs. local steroid injection for management of carpal tunnel syndrome: a randomized controlled trial.
OBJECTIVE: Local corticosteroid (CS) injection has been widely used to treat carpal tunnel syndrome, but its invasiveness can cause several complications. In this study, the authors tested the efficacy of a new treatment method, extracorporeal shock wave therapy (ESWT), compared with CS injection.
DESIGN: The authors carried out a randomized controlled trial comparing one session of ESWT (1000 shots at the maximal tolerable intensity) with one session of CS injection in 36 patients with carpal tunnel syndrome. Outcome measures including nerve conduction studies, a visual analog scale, and the Levine Self-assessment Questionnaire were performed at baseline and at 1 and 3 mos after treatment.
RESULTS: At baseline, there were no significant differences between the groups with respect to the outcome parameters. Both groups showed a significant reduction in the visual analog scale at 1 and 3 mos after treatment compared with baseline. For the symptom severity score on the Levine Self-assessment Questionnaire, the ESWT group showed a significant reduction at 1 and 3 mos after treatment, whereas the CS injection group showed a significant reduction at 3 mos after treatment. For the nerve conduction parameters, there were mild but no significant improvements in the ESWT group, whereas the sensory nerve conduction velocity, the sensory nerve action potential amplitude, and the distal sensory and motor latencies of the median nerve were significantly improved in the CS injection group.
CONCLUSIONS: ESWT can be as useful as CS injection for relieving symptoms of carpal tunnel syndrome. Furthermore, in contrast to CS injection, it has the merit of being noninvasive.
DESIGN: The authors carried out a randomized controlled trial comparing one session of ESWT (1000 shots at the maximal tolerable intensity) with one session of CS injection in 36 patients with carpal tunnel syndrome. Outcome measures including nerve conduction studies, a visual analog scale, and the Levine Self-assessment Questionnaire were performed at baseline and at 1 and 3 mos after treatment.
RESULTS: At baseline, there were no significant differences between the groups with respect to the outcome parameters. Both groups showed a significant reduction in the visual analog scale at 1 and 3 mos after treatment compared with baseline. For the symptom severity score on the Levine Self-assessment Questionnaire, the ESWT group showed a significant reduction at 1 and 3 mos after treatment, whereas the CS injection group showed a significant reduction at 3 mos after treatment. For the nerve conduction parameters, there were mild but no significant improvements in the ESWT group, whereas the sensory nerve conduction velocity, the sensory nerve action potential amplitude, and the distal sensory and motor latencies of the median nerve were significantly improved in the CS injection group.
CONCLUSIONS: ESWT can be as useful as CS injection for relieving symptoms of carpal tunnel syndrome. Furthermore, in contrast to CS injection, it has the merit of being noninvasive.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app